findmyKOL
Clinical trialNCT04230239CompletedPhase 2Interventional

Clinical Trial to Assess the Efficacy and Toxicity of Induction and Consolidation With CPX-351 for Patients Aged 60 to 75 Years With Secondary or High-risk Acute Myeloid Leukemia

SponsorPETHEMA FoundationEnrollment59Newly Diagnosed Secondary or High Risk AML
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Spain
  • Institut Català D'Oncologia-Hospital Germans Trias I Pujol

    Badalona, Spain

  • Institut Català D'Oncologia - Hospital Duran I Reynals

    Bellvitge, Spain

  • Hospital San Pedro de Alcántara

    Cáceres, Spain

  • Hospital Universitario Reina Sofía

    Córdoba, Spain

  • Hospital Universitario de Gran Canaria Dr. Negrín

    Las Palmas, Spain

  • Hospital Universitario Lucus Augusti

    Lugo, Spain

  • Hospital Ramón Y Cajal

    Madrid, Spain

  • Hospital Universitario 12 de Octubre

    Madrid, Spain

  • Hospital Universitario Central de Asturias

    Oviedo, Spain

  • Hospital General del H.U. Virgen del Rocío

    Seville, Spain

  • Hospital Clínico Universitario de Valencia

    Valencia, Spain

  • Hospital Universitario Y Politécnico la Fe

    Valencia, Spain

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
26 Dec 2019
Primary completion
30 Apr 2021
Completion
11 Aug 2021
Last update posted
25 Jun 2026
Registered enrollment
59
Registry id
NCT04230239

Cross-registrations

EU-CTR / CTIS (EudraCT)2018-004353-24

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.